Inhibikase Therapeutics, Inc.

Regulation FD Disclosure

Changes in Registrant's Certifying Accountant

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Unregistered Sales of Equity Securities

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Regulation FD Disclosure

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Annual Report Scanned (Paper)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Regulation FD Disclosure

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Other Events

Prospectus Supplement for Primary Offering

Entry into a Material Definitive Agreement

Prospectus Supplement for Primary Offering

Other Events

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Registration statement under Securities Act of 1933

Additional Information for Proxy Statement/ Votes

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Annual Report Scanned (Paper)

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Annual report pursuant to Section 13 or 15(d) (amendment)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Entry into a Material Definitive Agreement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Registration statement under Securities Act of 1933

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Correspondence with the SEC

Registration statement under Securities Act of 1933 (amendment)

Definitive Proxy Statement

Registration statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d)

Preliminary Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Registration (IPO) statement under Securities Act of 1933

Preliminary Proxy Statement

06b

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Annual Report Scanned (Paper)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Annual Report Scanned (Paper)

Definitive Proxy Statement

Preliminary Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Required Information in Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission)

Correspondence with the SEC

BERMAN DENNIS N

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; Kolchinsky Peter; Shah Rajeev M.

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; Kolchinsky Peter; Shah Rajeev M.

Munshi Amit

Bellini Roberto

BERMAN DENNIS N

Canner David

Kush Arvind

Aurentz Vincent

Munshi Amit